Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
Lexicon Pharmaceuticals (Nasdaq:LXRX) announced that company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026, at 2:00 p.m. ET in New York City.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Lexicon Pharmaceuticals (Nasdaq:LXRX) announced that company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026, at 2:00 p.m. ET in New York City.
The live event and replay will be available via the Events page of Lexicon's investor website.
Details
News Market Reaction – LXRX
On May 28, the day this news came out, LXRX closed 1.84% above the previous close.
Data tracked by StockTitan Argus for the May 28 session.
Key Figures
- Conference date
- June 4, 2026
- Jefferies Global Healthcare Conference fireside chat
- Event time
- 2:00 p.m. ET
- Scheduled start time for conference fireside chat
Historical Context
-
Announcement of fireside chat at H.C. Wainwright BioConnect conference.
-
Q1 2026 results with higher revenue and multiple clinical updates.
-
New Hercules loan facility providing up to $100M and refinancing prior debt.
-
Announcement of date and call details for Q1 2026 earnings release.
-
AAN Phase 2b data supporting pilavapadin 10 mg for Phase 3 planning.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
THE WOODLANDS, Texas, May 28, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026 at 2:00 p.m. ET in New York City.
The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.
About Lexicon Pharmaceuticals
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com.
For Media Inquiries:
Dave Belian
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
For Investor Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.